Results 621-640 of 1,147,017 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Tom Kitt OR speaker:Réada Cronin OR speaker:Simon Coveney OR speaker:Seán Sherlock OR speaker:Denise Mitchell OR speaker:Duncan Smith OR speaker:Fergus O'Dowd OR speaker:Michael Healy-Rae OR speaker:Jackie Cahill OR speaker:Niall Collins OR speaker:Mattie McGrath OR speaker:Michael Creed OR speaker:Pádraig O'Sullivan OR speaker:Éamon Ó Cuív OR speaker:Mick Barry OR speaker:David Cullinane OR speaker:Dessie Ellis OR speaker:Pauline Tully OR speaker:Paul Donnelly OR speaker:Joe Flaherty OR speaker:Neasa Hourigan OR speaker:Stephen Donnelly OR speaker:Catherine Martin OR speaker:Cian O'Callaghan OR speaker:Peter Fitzpatrick OR speaker:Micheál Martin OR speaker:Jennifer Carroll MacNeill OR speaker:Danny Healy-Rae OR speaker:Mairead Farrell OR speaker:Martin Browne OR speaker:Éamon Ó Cuív04 OR speaker:Ivana Bacik OR speaker:Patricia Ryan OR speaker:Robert Troy OR speaker:Éamon Ó Cuív15 OR speaker:Colm Burke OR speaker:Mark Ward)
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: It is anecdotal.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: It is fantastic. I thank the Chair.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: I was not sure what the time was, but I am fine.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I welcome our witnesses. I want to touch on stigma but before that I will go back to nurse prescribing. A lot of the discussion we are having today reminds me of when I followed the nurse prescribing journey in diabetes. It reminds me of that a lot, in that it is a lifestyle-based treatment and is very much about who you meet when you go into a clinic. At the front line that is often...
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I presume we should have non-elective modules within training for all medical professionals. Would that be specifically on addiction or would it be more useful for it be about what trauma-centred care looks like?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Would the other witnesses like to come in on addiction versus trauma led?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: The research suggests that when you are on the front line, those attitudes become more prevalent.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: That would take care of all of our new cohort. There are hundreds of thousands of people working in services that are central or tangential to our health service. How do we hit all of them? Do we need to get everybody into a continuing professional development course on addiction and trauma-like care?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: How far along are we on that journey?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Working in an emergency department is different from working in a laboratory.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I will return to the question of the inspection of services. I am a member of the Joint Committee on Health, where we talk a lot about the inspection side of things in the context of oversight, performance indicators and outcomes. Who would do that? Perhaps that is not fair. What kind of a body could the witnesses imagine undertaking that piece of work?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Could Dr. Kelly give me an idea of the breadth and level of that service? Would it include all the third-party and NGO services?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Would it influence how drug task forces work?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: It is crazy.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: By proxy, there would be a benchmark that you could fall below and therefore-----
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: I will not say what popped into my head. Just taking the piss.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: Not once or twice weekly, however. There is no benefit there.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: That was my experience. At some stage it was once weekly and if a doctor had concerns it was twice weekly. It was being used punitively.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I have a question about data which struck me when talking about the prisons. I was reading something about it. Do we have the data about how many persons are eligible for OST or who would be appropriate for OST? Not somebody who has tried a drug once, but somebody who would benefit from OST. How many are actually in treatment? One statistic I read stated 35% of people who should be in...
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Yes, of course. To be honest, my question was not just what the number is but whether we are recording the data. When I ask a question about health, I am often told it is not recorded. As a result, I was wondering whether we have a sense of the data.